SciBase decides on a directed issue of approximately SEK 22.5 million and a rights issue of up to approximately SEK 59.3 million - Finansavisen
| SCIB Stock | SEK 0.42 0.03 7.69% |
Slightly above 55% of Scibase AB's private investors are presently thinking to get in. The analysis of current outlook of investing in Scibase AB suggests that some traders are interested regarding Scibase AB's prospects. Scibase AB's investing sentiment can be driven by a variety of factors including economic data, Scibase AB's earnings reports, geopolitical events, and overall market trends.
Scibase |
SciBase decides on a directed issue of approximately SEK 22.5 million and a rights issue of up to approximately SEK 59.3 million Finansavisen
Read at news.google.com
 |
Scibase AB Fundamental Analysis
We analyze Scibase AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Scibase AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Scibase AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Scibase AB is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Scibase AB Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Scibase AB stock to make a market-neutral strategy. Peer analysis of Scibase AB could also be used in its relative valuation, which is a method of valuing Scibase AB by comparing valuation metrics with similar companies.
Peers
Scibase AB Related Equities
| ACARIX | Acarix AS | 12.00 | ||||
| SES | Scandinavian Enviro | 3.51 | ||||
| CANTA | Cantargia | 0.54 | ||||
| XBRANE | Xbrane Biopharma | 5.88 | ||||
| EPIS-B | Episurf Medical | 7.69 |
Additional Tools for Scibase Stock Analysis
When running Scibase AB's price analysis, check to measure Scibase AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scibase AB is operating at the current time. Most of Scibase AB's value examination focuses on studying past and present price action to predict the probability of Scibase AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scibase AB's price. Additionally, you may evaluate how the addition of Scibase AB to your portfolios can decrease your overall portfolio volatility.